Case Studies

George Clinical Team Guides Unique Multiple Sclerosis Trial Through Difficult Circumstances

Challenges included specialized equipment, interaction with multiple departments and stringent COVID restrictions.

George Clinical Renal Scientific Leadership Team Keeps Recruitment on Target in Difficult CKD Study

Despite operational delays, COVID interruptions and Ukraine war outbreak, targets were met.    

Established Relationships Allow George Clinical to Meet Tight Timelines and Recruitment Challenges in Critical Early Phase Oncology Study

Local knowledge combined with Australia’s favorable conditions keep trial on track and on time. Early phase clinical trials are the first-line research studies in drug development and assess therapies for safety, dosage levels and side effects. These studies form the basis for all further research on therapy, so they must be conducted to very high […]

George Clinical Brings Robust Retention Strategy and Tactics to Global Rare Renal Disease Studies

We work to keep every patient engaged to the end from risk retention and personal contact with clinical research associates (CRAs) to patient-facing animation in 20 languages. Clinical trials for rare diseases pose specific challenges due to their elusive nature and low patient populations. Research is critical for these often serious and even life-threatening diseases […]

Global and National Scientific Leadership Helps Move Potential Breakthrough CKD Anemia Treatment Forward

Exceptional kidney and metabolic scientific leadership network provides continuity, communication and cultural expertise in long-term global trial program.   Background The National Institute of Diabetes and Digestive and Kidney Diseases (NIH) estimates that more than one in seven people with kidney disease have anemia, increasing their chance of developing heart problems and strokes. The prevalence […]

George Clinical Conducts First Oncology Immunonutrition Trial in China

George Clinical’s Scientific Leadership Model Proves Critical to Meeting Difficult Recruitment Targets in Atypical Phase I Study of a New Renal Drug

Having a well-respected clinician as part of the team to communicate the scientific value of the research gave valuable credibility and comfort level to referring physicians. George Clinical was contracted by a mid-size pharmaceutical company to conduct project management and clinical monitoring in a study to evaluate the pharmacokinetics (PK) and safety of a sulfated […]

George Clinical’s Scientific Leadership Achieves Exceptional Integration Between Science and Operations with Unprecedented Low Rates of Loss to Follow Up and Withdrawal of Consent

Landmark CREDENCE renal outcomes trial stopped early based on achievement of pre-specified efficacy criteria.   SITUATION Five million people are predicted to have kidney failure by 2035. This is a global problem causing not only a diminished quality of life for patients, who are at risk for many adverse health outcomes, but also creating great […]